Mimicry and deception in inflammatory bowel disease and intestinal Behçet disease.
Behçet disease (BD) is a rare, chronic, multisystemic, inflammatory disease characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. Intestinal BD occurs in 10-15% of BD patients and shares many clinical characteristics with inflammatory bowel disease (IBD), making...
| Publicado en: | Gastroenterology & Hepatology Vol. 8; no. 2; pp. 103 - 113 |
|---|---|
| Autores principales: | , , |
| Formato: | algorithm review tables/charts Journal Article |
| Publicado: |
Gastro-Hep Communications, Inc
Feb2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104517409&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104517409 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15547914 6N5B jtl: Gastroenterology & Hepatology issn: 15547914 maglogo: N pubinfo: dt: Feb2012 vid: 8 iid: 2 pid: 72163 pub: Gastro-Hep Communications, Inc place: New York, New York artinfo: ui: 104517409 104517409 2011454249 NLM22485077 104517409 ppf: 103 ppct: 10 formats: fmt: @attributes: type: P tig: atl: Mimicry and deception in inflammatory bowel disease and intestinal Behçet disease. aug: au: Grigg, Erika L Kane, Sunanda Katz, Seymour affil: Georgia Health Sciences University in Augusta, GA sug: subj: Behcet's Syndrome Diagnosis Diagnosis, Differential Inflammatory Bowel Diseases Diagnosis Tumor Necrosis Factor Antagonists and Inhibitors Algorithms Antibodies Blood Behcet's Syndrome Epidemiology Behcet's Syndrome Physiopathology Behcet's Syndrome Radiography Behcet's Syndrome Symptoms Endoscopy Inflammatory Bowel Diseases Radiography Inflammatory Bowel Diseases Symptoms Severity of Illness Surgery, Operative ab: Behçet disease (BD) is a rare, chronic, multisystemic, inflammatory disease characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. Intestinal BD occurs in 10-15% of BD patients and shares many clinical characteristics with inflammatory bowel disease (IBD), making differentiation of the 2 diseases very difficult and occasionally impossible. The diagnosis of intestinal BD is based on clinical findings--as there is no pathognomonic laboratory test--and should be considered in patients who present with abdominal pain, diarrhea, weight loss, and rectal bleeding and who are susceptible to intestinal BD. Treatment for intestinal BD is similar to that for IBD, but overall prognosis is worse for intestinal BD. Although intestinal BD is extremely rare in the United States, physicians will increasingly encounter these challenging patients in the future due to increased immigration rates of Asian and Mediterranean populations. pubtype: Academic Journal doctype: algorithm review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|